VasocureĀ
HealthcareĀ
The world's first drug to treat neointimal disease
Ā
Vasocure is a clinical-stage nephrology therapeutics company with the world's first peptide to directly treat neointimal hyperplasia, or neointimal disease, arteriosclerosis, and atherosclerosis. Learn more atĀ vasocuretherapeutics.com.
As their creative partner, we provided:Ā
Logo designĀ
Behind the scenes
Video shoot and photography session at our New York City office.Ā
Discover a modern approach to content production
Book intro call
